Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • April 26, 2024, 17:46 UTC
  • 45
  • 0 comments

FDA approve DIGOXIN

Comment Full text

ALVOGEN

  • FDA Approval
  • April 26, 2024, 17:43 UTC
  • 42
  • 0 comments

FDA approve LABETALOL HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 44
  • 0 comments

FDA approve AMOXICILLIN

Comment Full text

AMGEN INC

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 41
  • 0 comments

FDA approve APREMILAST

Comment Full text

HIKMA

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 38
  • 0 comments

FDA approve AMOXICILLIN

Comment Full text

SPH SHANGHAI ZHONGXI PHARMA CO LTD

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 43
  • 0 comments

FDA approve ESLICARBAZEPINE ACETATE

Comment Full text

LIVZON GRP

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 49
  • 0 comments

FDA approve CETRORELIX ACETATE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 47
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

EUGIA PHARMA SPECLTS

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 40
  • 0 comments

FDA approve AMPICILLIN SODIUM

Comment Full text

TEVA

  • FDA Approval
  • April 26, 2024, 09:03 UTC
  • 43
  • 0 comments

FDA approve NORTRIPTYLINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 468
  • 469
  • 470
  • 471
  • 472
  • Next

Search

News categories

  • Technical Exchange News(11662)
  • Event(3945)
  • SEC News(229945)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(141247)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin